Despite these potential advantages for IL-15, IL-2–anti-IL-2 complexes were superior to IL-15–soluble IL-15Rα complexes at supporting the anti-tumor activity of transferred CD8+ T cells57. The gene discussed is IL15; the disease is neoplasm.